http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2677631-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bdd619b8a2cc2f110b9ee4dc8d896a17
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-186
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335
filingDate 2007-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b22dfd657eb0c4e6a240ddf654f5c42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd397053ac2814b18a55cb38153e5a21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b185675e65abbf3d0d0929274c7ae502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93ff5216333e3dde89a59f12debe732a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99462bd4a0bcebc0f73bc5320f363557
publicationDate 2008-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2677631-A1
titleOfInvention Olopatadine formulations for topical nasal administration
abstract Topical formulations of olopatadine for treatment of allergic or inflamma tory disorders of the nose are disclosed. The aqueous formulations contain a pproximately 0.6 % (w/v) of olopatadine.
priorityDate 2007-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447917097
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23672064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450254702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6398980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454515022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413339604
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454620584
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452546156
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449122806
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3908
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451483296
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425188129
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447574277
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3908
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535285

Total number of triples: 55.